AGP Executive Report
Last update: 2 hours agoBiotech Milestone: Tiziana Life Sciences says it has finished enrolling 48 patients in its Phase 2a INFORM-MS trial of intranasal foralumab for non-active secondary progressive multiple sclerosis, with topline results due late Q3 2026 and a blinded-to-open-label switch for all participants. Clinical Tech in Public Safety: Responsibility.org and Cambridge Health Alliance launched CARS Connect, a cloud version of a DUI mental-health and substance-use screening tool meant to route impaired-driving cases to treatment faster. Hospital Ops AI: LiveData rolled out LiveData Insights AI Advisor, letting hospital leaders ask plain-language questions about operating-room performance for quicker answers than dashboards and ad-hoc reports. Security Market Signal: Rapid7’s Q1 threat report finds vulnerability exploitation overtook social engineering as the top initial access route, with attackers increasingly using issues that don’t require user action. Capital Markets: Nanobiotix priced a global follow-on offering and also announced trading resumption on Euronext Paris. Health & Robotics: Chinese researchers reported a wearable rehab robot for children with severe muscular atrophy, built with MIT and published in Nature.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
